WILLIAM DALTON, MD
Osteopathic Medicine at Usf Magnolia Dr, Tampa, FL
License number
Florida ME81307
Category
Osteopathic Medicine
Type
Medical Oncology
Address
Address
2
12902 Usf Magnolia Dr, Tampa, FL 33612
PO Box 917770, Orlando, FL 32891
PO Box 917770, Orlando, FL 32891
Phone
(813) 745-4673
Personal information
See more information about WILLIAM DALTON at radaris.comName
Address
Phone
4904 Watervista Dr, Orlando, FL 32821
505 S Riverhills Dr, Tampa, FL 33617
4401 N Suncoast Blvd LOT 6, Crystal River, FL 34428
58 Lakeview Dr, Venice, FL 34287
1318 Hawaii Ave, Palm Harbor, FL 34683
Organization information
See more information about WILLIAM DALTON at bizstanding.comWilliam Dalton MD,PHD
12902 Usf Magnolia Dr, Tampa, FL 33612
Industry:
Internist
Phone:
(813) 745-4673 (Phone)
William Steven Dalton
Professional information
William Steven Dalton, Tampa FL
Specialties:
Oncologist
Address:
12902 Magnolia Drive, Tampa, FL 33612
Education:
Indiana University, School of Medicine - Doctor of Medicine
University Medical Center - Fellowship - Oncology (Internal Medicine)
University Medical Center - Residency - Internal Medicine
University Medical Center - Fellowship - Oncology (Internal Medicine)
University Medical Center - Residency - Internal Medicine
Board certifications:
American Board of Internal Medicine Certification in Internal Medicine, American Board of Internal Medicine Sub-certificate in Oncology (Internal Medicine)
Computer Systems And Methods For Selecting Subjects For Clinical Trials
US Patent:
8095389, Jan 10, 2012
Filed:
Jul 16, 2007
Appl. No.:
11/879387
Inventors:
William S. Dalton - Temple Terrace FL, US
Timothy Yeatman - Thonotasassa FL, US
Timothy Yeatman - Thonotasassa FL, US
Assignee:
H. Lee Moffitt Cancer Center and Research Institute, Inc. - Tampa FL
University of South Florida - Tampa FL
University of South Florida - Tampa FL
International Classification:
G06Q 50/00, C12Q 1/68
US Classification:
705 3, 705 2, 435 6
Abstract:
Computers, computer program products, and methods for identifying a plurality of subjects for a clinical trial are provided. A candidate set of molecular profiles in a stored plurality of molecular profiles are identified. Each such profile has measurements for a discriminating set of cellular constituents that match the measurements of corresponding cellular constituents in a responder set of biological samples, thereby identifying the plurality of subjects for the trial from those subjects from which the candidate set of molecular profiles were derived. Each respective molecular profile in the stored plurality of profiles has measurements of a plurality of cellular constituents from a respective biological sample in a plurality of samples obtained from a first plurality of subjects. The discriminating set of cellular constituents is identified from those cellular constituents in the plurality of cellular constituents whose measurement values discriminates between the responder and nonresponder sets of biological samples.
Computer Systems And Methods For Providing Health Care
US Patent:
8135595, Mar 13, 2012
Filed:
May 14, 2004
Appl. No.:
10/846977
Inventors:
William S. Dalton - Temple Terrace FL, US
Assignee:
H. Lee Moffitt Cancer Center and Research Institute, Inc. - Tampa FL
International Classification:
G06Q 10/00, G06Q 50/00, C12Q 1/68
US Classification:
705 2, 705 3, 435 6
Abstract:
The invention provides a computer network comprising a first computer and one or more second computers that are in electronic communication with each other. The first computer is associated with a first health care facility and has instructions for retrieving, over a network, one or more data structures for a patient enrolled in a health care program. The one or more data structures for the patient collectively comprise (i) a patient identifier, (ii) a molecular profile from a biological specimen obtained from the patient at the first health care facility; and (iii) a clinical characterization of the patient that was made at the first health care facility. The first computer has instructions for retrieving, over the network connection, one or a plurality of treatment regimens that are deemed suitable for the patient based upon the molecular profile and the clinical characterization of the patient. The one or more second computers are at one or more locations other than the first health care facility and have one or more data structures for each patient in a plurality of patients enrolled in the health care program.
Computer System And Computer-Implemented Method For Providing Personalized Health Information For Multiple Patients And Caregivers
US Patent:
2010007, Mar 25, 2010
Filed:
Aug 6, 2009
Appl. No.:
12/537126
Inventors:
William S. Dalton - Temple Terrace FL, US
Paul Jacobsen - Tampa FL, US
David A. Fenstermacher - Tampa FL, US
Paul Jacobsen - Tampa FL, US
David A. Fenstermacher - Tampa FL, US
Assignee:
H.LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE, INC. - Tampa FL
UNIVERSITY OF SOUTH FLORIDA - Tampa FL
UNIVERSITY OF SOUTH FLORIDA - Tampa FL
International Classification:
G06Q 50/00, G06Q 10/00, G06F 17/30
US Classification:
705 3, 705 2, 707780, 707E1706
Abstract:
Personalized health information is provided by maintaining a patient profile over time and matching information from the patient profile to appropriate patient-centric information related to that patient's specific medical condition. The patient profile can include a variety of medical information. The patient profile is matched, for example, to patient-centric options for care, clinical trials for which the patient is eligible, drug treatment regimens directly related to each patient's specific condition, scheduling of the treatments, survivorship plans and data, information about managing symptoms, nutritional information, rehabilitation recommendations, possible adverse events based on specific treatments to monitor, and personalized education and information. The patient profile can be populated with information from a database, such as one associated with a cancer registry.
Computer Systems And Methods For Selecting Subjects For Clinical Trials
US Patent:
8175896, May 8, 2012
Filed:
Aug 8, 2011
Appl. No.:
13/205536
Inventors:
William S. Dalton - Temple Terrace FL, US
Timothy Yeatman - Thonotasassa FL, US
Timothy Yeatman - Thonotasassa FL, US
Assignee:
H. Lee Moffitt Cancer Center and Research Institute, Inc. - Tampa FL
University of South Florida - Tampa FL
University of South Florida - Tampa FL
International Classification:
G06Q 50/00, C12Q 1/68
US Classification:
705 3, 705 2, 435 6
Abstract:
Computers, computer program products, and methods for identifying a plurality of subjects for a clinical trial are provided. A candidate set of molecular profiles in a stored plurality of molecular profiles are identified. Each such profile has measurements for a discriminating set of cellular constituents that match the measurements of corresponding cellular constituents in a responder set of biological samples, thereby identifying the plurality of subjects for the trial from those subjects from which the candidate set of molecular profiles were derived. Each respective molecular profile in the stored plurality of profiles has measurements of a plurality of cellular constituents from a respective biological sample in a plurality of samples obtained from a first plurality of subjects. The discriminating set of cellular constituents is identified from those cellular constituents in the plurality of cellular constituents whose measurement values discriminates between the responder and nonresponder sets of biological samples.
Compounds And Methods For Modulating Cell-Adhesion Mediated Drug Resistance
US Patent:
2008005, Feb 28, 2008
Filed:
Mar 30, 2007
Appl. No.:
11/731947
Inventors:
William Dalton - Tampa FL, US
Jason Damiano - Tampa FL, US
Anne Cress - Tucson AZ, US
Jason Damiano - Tampa FL, US
Anne Cress - Tucson AZ, US
International Classification:
A61K 38/08, A61K 38/00, A61P 35/00
US Classification:
514015000, 514002000
Abstract:
Peptides and methods of their use for inhibiting drug and radiation-therapy resistance in cancerous cells in which efficacy of chemotherapy and/or radiotherapy of a patient is enhanced by administration of an effective amount of a peptide that inhibits cell adhesion mediated drug resistance (CAM-DR). Preferably, the peptide comprises D-amino acids having the sequence:
or is a variant or modified version thereof. The peptide is preferably administered to the patient prior to chemotherapy and/or radiation therapy. Inhibition of cell adhesion mediated drug resistance (CAM-DR) by RZ-3 in multiple myeloma cells is disclosed.
Stat3 Agonists And Antagonists And Therapeutic Uses Thereof
US Patent:
2004005, Mar 18, 2004
Filed:
Sep 2, 2003
Appl. No.:
10/380020
Inventors:
Hua Yu - Tampa FL, US
Drew Pardoll - Brookeville MD, US
Richard Jove - Tampa FL, US
William Dalton - Tampa FL, US
Drew Pardoll - Brookeville MD, US
Richard Jove - Tampa FL, US
William Dalton - Tampa FL, US
International Classification:
A61K038/20, A61K038/17
US Classification:
424/085200, 514/002000
Abstract:
The present invention relates to methods for modulating, i.e., agonizing or antagonizing, Stat3 (Signal Transducer and Activator of Transcription3) signaling activity for use in gene therapy. Inhibition and/or activation of Stat3 signaling is an effective approach to modulate angiogenesis and the immune response for treatment and/or prevention of inflammation, infection, inflammation, immune disorders, and ischemia.
Methods For Modulating Cell-Adhesion Mediated Drug Resistance
US Patent:
2003000, Jan 2, 2003
Filed:
Dec 21, 2001
Appl. No.:
10/024018
Inventors:
William Dalton - Tampa FL, US
Jason Damiano - Tampa FL, US
Jason Damiano - Tampa FL, US
International Classification:
A61K031/66, A61N005/00
US Classification:
514/102000, 600/001000
Abstract:
A method for inhibiting cell adhesion mediated drug resistance wherein an effective amount of a bisphosphonate compound or a pharmaceutically acceptable bisphosphonate salt is administered to a patient having cancer, whereby the efficacy of chemotherapy or radiotherapy directed against the cancer is enhanced. Preferably, the bisphosphonate compound is etidronate, clodronate, pamidronate, or zoledronate. The bisphosphonate compound is preferably administered to the patient prior to the administration of chemotherapy or radiation therapy. Inhibition of cell adhesion mediated drug resistance (CAM-DR) by bisphosphonate in multiple myeloma cells is disclosed.
Stat3 Agonists And Antagonists And Therapeutic Uses Thereof
US Patent:
2009022, Sep 10, 2009
Filed:
Apr 8, 2009
Appl. No.:
12/420704
Inventors:
Hua Yu - Tampa FL, US
Drew Pardoll - Brookeville MD, US
Richard Jove - Tampa FL, US
William Dalton - Temple Terrace FL, US
Drew Pardoll - Brookeville MD, US
Richard Jove - Tampa FL, US
William Dalton - Temple Terrace FL, US
Assignee:
Johns Hopkins University - Baltimore MD
University of South Florida - Tampa FL
University of South Florida - Tampa FL
International Classification:
A61K 38/02, A61K 31/7105, A61K 31/711
US Classification:
514 8, 514 44 A
Abstract:
The present invention relates to methods for modulating, i.e., agonizing or antagonizing, Stat3 (Signal Transducer and Activator of Transcription3) signaling activity for use in gene therapy. Inhibition and/or activation of Stat3 signaling is an effective approach to modulate angiogenesis and the immune response for treatment and/or prevention of inflammation, infection, inflammation, immune disorders, and ischemia.
Value Network
US Patent:
8131567, Mar 6, 2012
Filed:
Feb 7, 2011
Appl. No.:
13/022452
Inventors:
William S. Dalton - Temple Terrace FL, US
Assignee:
H. Lee Moffitt Cancer Center and Research Institute, Inc. - Tampa FL
International Classification:
G06Q 10/00, G06Q 50/00, C12Q 1/68
US Classification:
705 2, 705 3, 435 4, 435 5
Abstract:
Systems and methods including a computer network are provided. The computer network includes a plurality of affiliate computing systems, each affiliate computing system including a processing unit and storage, the processing unit executing one or more programs for supporting care of a patient. The computer network includes a centralized care network including a central health care computing system, the central health care computing system being coupled to each affiliate computing system by way of a network and including a processing unit and storage, the processing unit executing one or more programs for managing patient records stored in the storage.